Ergocalciferol
Ergocalciferol is vitamin D2, taken by mouth as a capsule to treat hypoparathyroidism, refractory (vitamin D resistant) rickets, and familial hypophosphatemia.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 31 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
How we combine label and product data →
Patient information guide — a plain-language walkthrough of Ergocalciferol, written from its FDA label.
What Ergocalciferol is used for
▾
Ergocalciferol capsules are used for three conditions. Every product covered here lists the same uses.
- Hypoparathyroidism
- Refractory rickets (vitamin D resistant rickets)
- Familial hypophosphatemia
How Ergocalciferol works
▾
Ergocalciferol is vitamin D2. The liver and then the kidneys convert it into its active forms. Those forms help the small intestine absorb calcium and phosphorus, which raises blood levels enough to allow bone mineralization.
They also pull calcium and phosphate from bone and probably help the kidneys hold on to calcium. Parathyroid hormone regulates the kidney step.
Ergocalciferol dosage
▾
Ergocalciferol is taken by mouth as a capsule, generally once daily. Your prescriber sets the dose based on your condition and adjusts it with close monitoring.
- The gap between a helpful and a toxic dose is narrow.
- People with hypoparathyroidism may also be given calcium lactate along with it.
- Get enough calcium in your diet.
- Expect blood calcium and phosphorus tests every 2 weeks or more often, and monthly bone X-rays until things are stable.
Always follow your prescriber's directions and the label.
Dosing details from the FDA-approved label
From the Ergocalciferol prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Vitamin D Resistant Rickets
- 12,000 to 500,000 IU units daily
- Hypoparathyroidism
- 50,000 to 200,000 IU units daily concomitantly with calcium lactate 4 g, six times per day
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW. Vitamin D Resistant Rickets: 12,000 to 500,000 USP units daily. Hypoparathyroidism: 50,000 to 200,000 USP units daily concomitantly with calcium lactate 4 g, six times per day. DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION. Calcium intake should be adequate. Blood calcium and phosphorous determinations must be made every 2 weeks or more frequently if necessary. X-rays of the bones should be taken every month until condition is corrected and stabilized.
Read the full Dosage and Administration section on DailyMed →
Ergocalciferol side effects
▾
Common side effects
- Nausea
- Loss of appetite
- Constipation
- Weight loss
- Vague aches, stiffness and weakness
When to get medical help
- Call your doctor if you have excessive thirst, frequent urination, or need to urinate at night. These can be signs of too much vitamin D.
- Get medical help for nausea, weakness, loss of appetite, constipation, or weight loss that persists or worsens. These can be signs of high calcium.
- Seek urgent care for confusion, stupor, or dehydration, which can signal a high-calcium emergency.
- Tell your doctor about new high blood pressure or changes in kidney function.
Most side effects come from too much vitamin D and high blood calcium.
- Nausea
- Loss of appetite
- Constipation
- Weight loss
- Vague aches, stiffness and weakness
Call your doctor promptly if you notice heavy thirst, frequent urination, or kidney problems. Too much vitamin D can also cause high blood pressure and calcium deposits in soft tissues.
Ergocalciferol warnings and precautions
▾
- Vitamin D toxicity: The dose range between helpful and toxic is narrow.
- Kidney and heart effects: Too much can damage the kidneys. It can cause calcium deposits in the heart, blood vessels, and lungs. Rarely, it can be fatal.
- Lingering effects: Effects can last two or more months after stopping.
- Infants: Infants with idiopathic hypercalcemia may be sensitive to vitamin D.
- Keep out of the reach of children.
Ergocalciferol interactions
▾
Two interactions are named on the label.
- Mineral oil: It interferes with absorption of fat-soluble vitamins, including vitamin D.
- Thiazide diuretics: In people with hypoparathyroidism taking ergocalciferol, they may cause high blood calcium.
Interactions listed in the FDA-approved label
From the Ergocalciferol prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Mineral oil: Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations.
- Thiazide diuretics: Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia.
Read the label’s full interactions text
Drug Interactions Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations. Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Ergocalciferol
▾
- Do not use it with high blood calcium (hypercalcemia).
- Do not use it with a malabsorption syndrome.
- Do not use it with hypervitaminosis D or abnormal sensitivity to vitamin D's toxic effects.
- Infants with idiopathic hypercalcemia need vitamin D strictly restricted.
- Tell your prescriber about all your medicines, especially water pills and mineral oil.
Ergocalciferol overdose
▾
Too much vitamin D causes high blood calcium. Signs include poor appetite, nausea, weakness, weight loss, constipation, heavy thirst, and frequent urination. Treatment means stopping the vitamin right away, eating a low-calcium diet, and drinking plenty of fluids. Severe cases with dehydration, stupor, or coma need hospital care. Recovery is usual if no permanent damage has occurred.
What Ergocalciferol does in the body
▾
Active vitamin D metabolites raise blood calcium and phosphate by increasing absorption from the intestine. They also mobilize calcium and phosphate from bone. This supports bone mineralization.
How your body processes Ergocalciferol
▾
The liver first converts ergocalciferol to 25-hydroxyvitamin D. The kidneys then convert it to the active 1,25-dihydroxyvitamin D. Because of these steps, there is a 10 to 24 hour delay before it starts working. Its effects can last two or more months after treatment stops.
How to store Ergocalciferol
▾
Store at 25° C (77° F); excursionns permitted to 15° - 30° C (59° - 86° F) Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Ergocalciferol: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Ergocalciferol — the kind of thing our pharmacy team would talk through with you at the counter.
What is ergocalciferol for?
▾
How should I take it?
▾
Why do I need so many blood tests?
▾
What side effects should I watch for?
▾
Can I take it with other medicines?
▾
Who shouldn't take it?
▾
Is Ergocalciferol available over the counter?
▾
When was Ergocalciferol first available?
▾
Who makes Ergocalciferol?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Ergocalciferol on HelloPharmacist
Ergocalciferol forms and strengths (how it comes)
Ergocalciferol is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Drisdol is used to treat hypoparathyroidism, refractory (vitamin D resistant) rickets, and familial hypophosphatemia.
- Ergocalciferol capsules are used for the same three conditions.
- Vitamin D capsules (ergocalciferol) are used for the same three conditions.
- Drisdol is taken by mouth, and the dose is individualized under close medical supervision.
- Ergocalciferol capsules are taken by mouth, with blood calcium and phosphorus checked every 2 weeks or more often.
- Ergocalciferol (Vitamin D2) capsules call for adequate calcium intake and monthly bone X-rays until the condition is stable.
Ergocalciferol on the U.S. market: products, makers and brands
How Ergocalciferol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
33 companies list 94 Ergocalciferol product records with the FDA, mostly as capsule; the earliest marketing or approval year on record is 1974. Brand names on the directory include Drisdol, Calcidol, Vitamin D; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Ergocalciferol is used (Medicaid data)
A general measure of how commonly Ergocalciferol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ergocalciferol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ergocalciferol prescribed? Of the 1,600 medications we measure, Ergocalciferol ranks #17 by Medicaid prescriptions — more than 99% of them.
Utilization by Ergocalciferol product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ergocalciferol 1.25 MG Oral Capsule
Summed across the 7 of 179 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1367410
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ergocalciferol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 7 of 179 listed Ergocalciferol NDCs with Medicaid activity.
Compare Ergocalciferol products
A representative set of FDA-listed product records for Ergocalciferol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 1.25 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 1.25 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 8 listings | ANDA | View NDC → |
| 1.25 mg | Oral | AvKARE × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | AvPAK × 3 listings | ANDA | View NDC → |
| 1.25 mg | — | Banner Pharmacaps Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1.25 mg | Oral | Bionpharma Inc. × 3 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Bryant Ranch Prepack × 16 listings | ANDA | View NDC → |
| 1.25 mg | — | Catalent Pharma Solutions, LLC × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1.25 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 1.25 mg | Oral | Denton Pharma, Inc. dba Northwind Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.25 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 1.25 mg | Oral | Northwind Pharmaceuticals, LLC | ANDA | View NDC → |
| 1.25 mg | Oral | NuCare Pharmaceuticals,Inc. × 6 listings | ANDA | View NDC → |
| 1.25 mg | Oral | NuCare Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 50000 [IU] | — | Patheon Softgels Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1.25 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 6 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Preferred Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 1.25 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Remedyrepack Inc. × 8 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Rising Pharamceuticals, Inc | ANDA | View NDC → |
| 1.25 mg | Oral | St. Mary's Medical Park Pharmacy × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Strides Pharma Science Limited × 2 listings | ANDA | View NDC → |
| 1.25 mg | Oral | Torrent Pharmaceuticals Limited × 3 listings | NDA | View NDC → |
| 1.25 mg | Oral | Validus Pharmaceuticals LLC × 2 listings | NDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Formosa Laboratories, Inc. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Synthesia, a.s. | BULK INGREDIENT | View NDC → |
Showing 94 of 94 products — FDA National Drug Code Directory. See every product, package size and price: browse all 94 Ergocalciferol NDCs →
Ergocalciferol side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ergocalciferol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ergocalciferol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ergocalciferol FDA approval history
How Ergocalciferol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ergocalciferol recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Ergocalciferol recalls since July 2021.
✅No Ergocalciferol recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 4018 3 dose forms · 7 strengths
-
Dose form (SCDF) Oral Capsule RxCUI 372035In current FDA listings -
Dose form (SCDF) Oral Solution RxCUI 372039No current FDA listingClinical drug / strength (SCD) 0.2 MG/MLRxCUI 237723 -
Dose form (SCDF) Oral Tablet RxCUI 372040No current FDA listingClinical drug / strength (SCD) 0.01 MGRxCUI 1998320.05 MGRxCUI 12336640.25 MGRxCUI 1072631.25 MGRxCUI 310142
Look up RxCUI 4018 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ergocalciferol supply and shortage status
Whether Ergocalciferol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Ergocalciferol brand names
Ergocalciferol is sold under 3 brand names in the FDA directory — Drisdol, Calcidol, Vitamin D. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Ergocalciferol: manufacturers and labelers
33 companies list Ergocalciferol products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Aphena Pharma Solutions - Tennessee, LLC, Remedyrepack Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 9 more on the FDA NDC directory.
Ergocalciferol drug class (RxNorm)
Ergocalciferol belongs to the Provitamin D2 Compound class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Ergocalciferol page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Torrent Pharmaceuticals Limited is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →